Bellamy L, Casas ]P, Hingorani AD, et al: Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BM] 335:974, 2007
Benedetti T], Kates R, Williams V: Hemodynamic observations in severe preeclampsia complicated by pulmonary edema. Am ] Obstet Gynecol 152:330, 1985
Berg C], Harper MA, Atkinson SM, et al: Preventability of pregnancy-related deaths. Obstet Gynecol 106: 1228, 2005
Berks D, Steegers A, Molas M, et al: Resolution of hypertension and proteinuria after preeclampsia. Obstet Gynecol 114(6):1307,2009
Bloom SL, Leveno K]: Corticosteroid use in special circumstances: preterm ruptured membranes, hypertension, fetal growth restriction, multiple fetuses. Clin Obstet Gynecol 46: 150, 2003
Bokslag A, Franssen C, Teunissen PW, et al: Higher prevalence of diasto�ic dysfunction in women who have had a decade ago early onset preeclampSia. Abstract No. 66, Am] Obstet Gynecol 216:S47, 2017
Bolte AC, van Eyck], Gafar SF, et al: Ketanserin for the treatment of preeclampsia. ] Perinat Med 29: 14, 2001
Bombrys AE, Barton ]R, Habli M, Sibai BM: Expectant management of severe preeclampsia at 27(0/7) to 33(6/7) weeks' gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management. Am] Perinatol 26:441, 2009
Bombtys E, Barton ]R, Nowacki EA, et al: Expectant management of severe preeclampsia at less than 27 weeks' gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management. Am] Obstet Gynecol 199:247.e1, 2008
Bramham K, Briley AL, Seed P, et al: Adverse maternal and perinatal outcomes in women with previous preeclampsia: a prospective study. Am ] Obstet GynecoIn204(6):512.e1,n2011
Brewer ], Owens MY, Wallace K, et al: Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia. Amn] Obstet Gynecol 208(6):468.e1,n2013
Broekhuijsen K, van Baaren G], van Pampus MG, et al: Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial. Lancet 385(9986):2492, 2015
Brookield F, Su F, Elkomy MH, et al: Pharmacokinetics and placental transfer of magnesium sulfate in pregnant women. Am J Obstet Gynecol 214:737.e1,n2016
Brosens I, Pijnenborg R, Vercruysse L, et al: The "Great Obstetrical Syndromes" are associated with disorders of deep placentation. Am ] Obstet GynecoI204(3):193,n2011